Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?

Reproductive BioMedicine Online

Volumn 26, Issue 5, 2013, Pages 431-439

  Fleming, R ^a,b   Broekmans, F ^c   Calhaz Jorge, C ^d   Dracea, L ^e,f   Alexander, H ^g   Nyboe Andersen, A ^h   Blockeel, C ⁱ   Jenkins, J ^j   Lunenfeld, B ^k   Platteau, P ⁱ   Smitz, J ^l   De Ziegler, D ^m  

^a Glasgow Centre for Reproductive Medicine   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d HOSPITAL DE SANTA MARIA   (Portugal)

^e Clinica Medicala II   (Romania)

^f CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h Rigshospitalet   (Denmark)

ⁱ CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^j Ferring Pharmaceuticals AS   (Denmark)

^k BAR ILAN UNIVERSITY   (Israel)

^l VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^m CHU Cochin ^*  (France)

more..

Author keywords

anti M llerian hormone (AMH); GnRH agonist; GnRH antagonist; gonadotrophin releasing hormone; ovarian response; ovarian stimulation

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN;

DRUG DOSE COMPARISON; FERTILIZATION IN VITRO; HUMAN; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARIAN STIMULATION; OVARY FOLLICLE; PREDICTION; PREGNANCY OUTCOME; REVIEW; STIMULATION; TREATMENT RESPONSE;

ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 84877071036     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.02.027     Document Type: Review

References (51)

1. H. Al-Inany, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception Cochrane Database Syst. Rev. 2001 CD001750
2. H.G. Al-Inany, A.M. Abou-Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception Cochrane Database Syst. Rev. 3 2006 CD001750
3. H.G. Al-Inany, A.M. Abou-Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review Reprod. Biomed. Online 14 2007 640 649
4. W.M. Baarends, J.T. Uilenbroek, P. Kramer, J.W. Hoogerbrugge, E.C. van Leeuwen, A.P. Themmen, and J.A. Grootegoed Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth Endocrinology 136 1995 4951 4962
5. D.T. Baird Factors regulating the growth of the preovulatory follicle in the sheep and human J. Reprod. Fertil. 69 1983 343 352
6. M. Bals-Pratsch, K. Bühler, J. Krüssel, M. Wendelken, W. Dahncke, and M.S. Kupka Extended analyses of the German IVF Registry (D·I·R): andrological aspects, medical-economical assumptions related to the shift from IVF to ICSI and stimulation with gonadotropins J. Reproduktionsmed. Endokrinol. 7 2010 40 44
7. Z. Blumenfeld, T. Amit, R.J. Barkey, B. Lunenfeld, and J.M. Brandes Synergistic effect of growth hormone and gonadotropins in achieving conception in 'clonidine-negative' patients with unexplained infertility Ann. N. Y. Acad. Sci. 626 1991 250 265
8. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil. Steril. 91 2009 705 714
9. S.L. Broer, M. Dolleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum. Reprod. Update 17 2011 4654
10. S.F. Butts, and D.B. Seifer Six office tests to assess ovarian reserve, and what they tell you OGB Manage. 20 2008 29 40
11. R.L. Cate, R.J. Mattaliano, C. Hession, R. Tizard, N.M. Farber, A. Cheung, E.G. Ninfa, A.Z. Frey, D.J. Gash, E.P. Chow, R.A. Fisher, J.M. Bertonis, G. Torres, B.P. Wallner, K.L. Ramachandran, R.C. Ragin, T.F. Manganaro, D.T. MacLaughlin, and P.K. Donahoe Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells Cell 45 1986 685 698
12. C.L. Cook, Y. Siow, S. Taylor, and M.E. Fallat Serum mullerian-inhibiting substance levels during normal menstrual cycles Fertil. Steril. 73 2000 859 861
13. J.M. Duffy, G. Ahmad, L. Mohiyiddeen, L.G. Nardo, and A. Watson Growth hormone for in vitro fertilization Cochrane Database Syst. Rev. 2010 CD000099
14. M. Eilso Nielsen, I.A. Rasmussen, M. Fukuda, L.G. Westergaard, and C. Yding Andersen Concentrations of anti-Mullerian hormone in fluid from small human antral follicles show a negative correlation with CYP19 mRNA expression in the corresponding granulosa cells Mol. Hum. Reprod. 16 2010 637 643
15. R. Fleming, A.H. Adam, D.H. Barlow, W.P. Black, M.C. MacNaughton, and J.R. Coutts A new systematic treatment for infertile women with abnormal hormone profiles Br. J. Obstet. Gynaecol. 89 1982 80 83
16. R. Fleming, N. Deshpande, I. Traynor, and R.W. Yates Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone Hum. Reprod. 21 2006 1436 1441
17. R. Fleming, and J. Jenkins The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles Reprod. Biomed. Online 21 2010 446 449
18. J.A. Grootegoed, W.M. Baarends, and A.P. Themmen Welcome to the family: the anti-mullerian hormone receptor Mol. Cell. Endocrinol. 100 1994 29 34
19. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. Te Velde, and F.J. Broekmans Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J. Clin. Endocrinol. Metab. 91 2006 4057 4063
20. P. Humaidan, E.G. Papanikolaou, and B.C. Tarlatzis GnRHa to trigger final oocyte maturation: a time to reconsider Hum. Reprod. 24 2009 2389 2394
21. P. Humaidan, S. Kol, and E. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum. Reprod. Update 2011 http://dx.doi.org/10.1093/humupd/dmr1008 (Epub ahead of print)
22. E.R. Klinkert, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. te Velde Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial Hum. Reprod. 20 2005 611 615
23. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum. Reprod. Update 12 2006 651 671
24. A. Kumar, B. Kalra, A. Patel, L. McDavid, and W.E. Roudebush Development of a second generation anti-Müllerian hormone (AMH) ELISA J. Immunol. Methods 362 2010 51 59
25. A. La Marca, S. Malmusi, S. Giulini, L.F. Tamaro, R. Orvieto, P. Levratti, and A. Volpe Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation Hum. Reprod. 19 2004 2738 2741
26. A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe Serum anti-Mullerian hormone throughout the human menstrual cycle Hum. Reprod. 21 2006 3103 3107
27. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A.C. Artenisio, G. Stabile, and A. Volpe Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum. Reprod. Update 16 2010 113 130
28. A. La Marca, S.M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L. Roli, S. Xella, T. Marsella, D. Tagliasacchi, R. D'Amico, and A. Volpe Anti-Mullerian hormone-based prediction model for a live birth in assisted reproduction Reprod. Biomed. Online 22 2011 341 349
29. A. La Marca, A.N. Andersen, P. Devroey, B.M. Klein, and J.C. Arce IVF/ICSI patients predicted to be high responders by their AMH level may benefit from HP-hMG treatment Fertil. Steril. 98 2012 S51
30. T.G. Lainas, G.K. Petsas, I.Z. Zorzovilis, G.S. Iliadis, G.T. Lainas, H.E. Cazlaris, and E.M. Kolibianakis Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development Hum. Reprod. 22 2007 1540 1546
31. J.S. Laven, A.G. Mulders, J.A. Visser, A.P. Themmen, F.H. De Jong, and B.C. Fauser Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age J. Clin. Endocrinol. Metab. 89 2004 318 323
32. J.R. Lee, S.H. Kim, S.M. Kim, B.C. Jee, S.Y. Ku, C.S. Suh, Y.M. Choi, J.G. Kim, and S.Y. Moon Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction Hum. Reprod. 25 2010 2597 2604
33. D.N. Lekamge, M. Lane, R.B. Gilchrist, and K.P. Tremellen Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve J. Assist. Reprod. Genet. 25 2008 515 521
34. G.S. Nakhuda, N.C. Douglas, M.H. Thornton, M.M. Guarnaccia, R. Lobo, and M.V. Sauer Anti-Mullerian hormone testing is useful for individualization of stimulation protocols in oocyte donors Reprod. Biomed. Online 20 2010 42 47
35. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy Hum. Reprod. 22 2007 2414 2421
36. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, M. Gaudoin, P. Mitchell, P. Ambrose, and R. Fleming Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum. Reprod. 24 2009 867 875
37. S.M. Nelson, M.C. Messow, A. McConnachie, H. Wallace, T. Kelsey, R. Fleming, R.A. Anderson, and B. Leader External validation of nomogram for the decline in serum anti-Mullerian hormone in women: a population study of 15,834 infertility patients Reprod. Biomed. Online 23 2011 204 206
38. S.M. Nelson, M.C. Messow, A.M. Wallace, R. Fleming, and A. McConnachie Nomogram for the decline in serum antimullerian hormone: a population study of 9601 infertility patients Fertil. Steril. 95 2011 e731 733
39. F. Olivennes, C.M. Howles, A. Borini, M. Germond, G. Trew, M. Wikland, F. Zegers-Hochschild, H. Saunders, and V. Alam Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study Reprod. Biomed. Online 18 2009 195 204
40. Z. Pandian, A.R. McTavish, L. Aucott, M.P. Hamilton, and S. Bhattacharya Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database Syst. Rev. 2010 CD004379
41. L. Pellatt, S. Rice, and H.D. Mason Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction 139 2010 825 833
42. B. Popovic-Todorovic, A. Loft, H.E. Bredkjaeer, S. Bangsboll, I.K. Nielsen, and A.N. Andersen A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment Hum. Reprod. 18 2003 2275 2282
43. D.M. Robertson, G.E. Hale, I.S. Fraser, C.L. Hughes, and H.G. Burger Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age Menopause 18 2011 521 524
44. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil. Steril. 77 2002 468 471
45. M. Sowers, D. McConnell, K. Gast, H. Zheng, B. Nan, J.D. McCarthy, and J.F. Randolph Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles Fertil. Steril. 94 2010 1482 1486
46. S.K. Sunkara, V. Rittenberg, N. Raine-Fenning, S. Bhattacharya, J. Zamora, and A. Coomarasamy Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Hum. Reprod. 26 2011 1768 1774
47. E.R. te Velde, and P.L. Pearson The variability of female reproductive ageing Hum. Reprod. Update 8 2002 141 154
48. J. van Disseldorp, C.B. Lambalk, J. Kwee, C.W. Looman, M.J. Eijkemans, B.C. Fauser, and F.J. Broekmans Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts Hum. Reprod. 25 2010 221 227
49. C. Weenen, J.S. Laven, A.R. Von Bergh, M. Cranfield, N.P. Groome, J.A. Visser, P. Kramer, B.C. Fauser, and A.P. Themmen Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol. Hum. Reprod. 10 2004 77 83
50. A. Weghofer, W. Dietrich, D.H. Barad, and N. Gleicher Live birth chances in women with extremely low-serum anti-Mullerian hormone levels Hum. Reprod. 26 2011 1905 1909
51. A.P. Yates, O. Rustamov, S.A. Roberts, H.Y. Lim, P.W. Pemberton, A. Smith, and L.G. Nardo Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Hum. Reprod. 26 2011 2353 2362